Malignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha

Similar documents
Protocol applies to melanoma of cutaneous surfaces only.

Malignant tumors of melanocytes: Part 1. Deba P Sarma, MD., Omaha

Michael T. Tetzlaff MD, PhD

Primary Cutaneous Melanoma Pathology Reporting Proforma DD MM YYYY. *Tumour site. *Specimen laterality. *Specimen type

Dermatopathology. Dr. Rafael Botella Estrada. Hospital La Fe de Valencia

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

Histopathology of Melanoma

Update on 8 th Edition Cutaneous AJCC Staging of Primary Cutaneous Melanoma. Michael T. Tetzlaff MD, PhD

Tracking skin cancers and melanoma at the microscopic level

12. Malignant Melanoma of Skin

Pathology of the skin. 2nd Department of Pathology, Semmelweis University

Melanoma Case Scenario 1

Protocol for the Examination of Specimens From Patients With Melanoma of the Skin

Melanoma Case Scenario 1

Melanoma Underwriting Presented at 2018 AHOU Conference. Hank George FALU

WHAT DOES THE PATHOLOGY REPORT MEAN?

NAACCR Webinar Series 1

Identifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018

Skin Cancer. 5 Warning Signs. American Osteopathic College of Occupational and Preventive Medicine OMED 2012, San Diego, Monday, October 8, 2012 C-1

David B. Troxel, MD. Common Medicolegal Situations: Misdiagnosis of Melanoma

Melanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG

MALIGNANT MELANOMA OF THE HEEL

Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more

Uveal Melanoma. Protocol applies to malignant melanoma of the uvea.

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

Histopathology: skin pathology

Protocol for the Examination of Specimens From Patients With Melanoma of the Skin

Melanoma 6/2/2011. Classification and Prognosis. Melanoma Statistics. American Cancer Society

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition

IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY

Contrast with Australian Guidelines A/Pr Pascale Guitera,

Springer Healthcare. Staging and Diagnosing Cutaneous Melanoma. Concise Reference. Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix.

Melanoma 10/6/16. Please submit all questions concerning webinar content through the Q&A panel. Reminder:

Polypoid Melanoma, A Virulent Variant of the Nodular Growth Pattern

NAACCR Webinar Series 1

Breslow Thickness and Clark Level Evaluation in Albanian Cutaneous Melanoma

Melanoma. Kaushik Mukherjee MD A. Scott Pearson MD

Disorders of Cell Growth & Neoplasia. Histopathology Lab

HISTOPATHOLOGIC REPORTING OF MELANOCYTIC SKIN LESIONS. Problems, thoughts, proposals

Urinary Bladder, Ureter, and Renal Pelvis

Actinic keratosis (AK): Dr Sarma s simple guide

47. Melanoma of the Skin

Supporting Information

Clinical Pathological Conference. Malignant Melanoma of the Vulva

Melanoma. Consultation on draft guideline - stakeholder comments. Comments to be submitted before 5pm on Friday 13 March 2015

Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment

Directly Coded Summary Stage Melanoma

NAACCR Hospital Registry Webinar Series

Definition of Synoptic Reporting

Malignant Melanoma Early Stage. A guide for patients

The pathology of bladder cancer

Dermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.

An Overview of Melanoma. Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Glenn D. Goldman, MD. University of Vermont Medical Center. University of Vermont College of Medicine

Collaborative Stage for TNM 7 - Revised 07/14/2009 [ Schema ]

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Clinical characteristics

Melanoma Update: 8th Edition of AJCC Staging System

Carol Davila University of Medicine and Pharmacy, Bucharest, Romania b

Question: If in a particular case, there is doubt about the correct T, N or M category, what do you do?

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL

Protocol for the Examination of Specimens From Patients With Squamous Cell Carcinoma of the Skin

Collaborative Staging Manual and Coding Instructions Part II: Primary Site Schema

Multiple Primary Melanoma in a Thai Male: A Case Report

Modern therapy in oncology Metastatic melanoma

Epidemiology. Objectives 8/28/2017

Malignant Melanoma in Turkey: A Single Institution s Experience on 475 Cases

ISPUB.COM. Seborrheic Keratosis: A Pictorial Review of the Histopathologic Variations. D Sarma, S Repertinger

Pancreas (Exocrine) Protocol applies to all carcinomas of the exocrine pancreas.

Maligna Melanoma and Atypical Fibroxanthoma: An Unusual Collision Tumour G Türkcü 1, A Keleş 1, U Alabalık 1, D Uçmak 2, H Büyükbayram 1 ABSTRACT

Malignant melanoma of the eyelid skin:

Thin Melanoma. N Context. The incidence of malignant melanoma is

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES

Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc

Protocol for the Examination of Specimens from Patients with Melanoma of the Skin

Amelanotic melanoma of the skin detailed review of the problem

Carcinoma of the Skin

Growth rate of melanoma in vivo and correlation with dermatoscopic and dermatopathologic findings

Thyroid Gland. Protocol applies to all malignant tumors of the thyroid gland, except lymphomas.

Updates on Melanoma: Are You Following the Latest Guidelines of Care? Jerry Brewer, MD

Malignant Melanoma Introduction increasing incidence increasing mortality skin >50% normal skin pigmented lesion

The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.

Dr. Brent Doolan, BSc MBBS MPH

Impact of Prognostic Factors

INTRODUCTION TO CANCER STAGING

6/22/2015. Original Paradigm. Correlating Histology and Molecular Findings in Melanocytic Neoplasms

Standards and datasets for reporting cancers. Dataset for histopathological reporting of primary cutaneous malignant.

Assisting diagnosis of melanoma through the noninvasive biopsy of skin lesions

Prognosticators of melanoma, the melanoma report, and the sentinel lymph node

1. Written information to patient /GP: fax ASAP to GP & offer copy of consultation letter.

Protocol for the Examination of Specimens From Patients With Merkel Cell Carcinoma of the Skin

Retinoblastoma. Protocol applies to retinoblastoma only.

Case Report A Rare Cutaneous Adnexal Tumor: Malignant Proliferating Trichilemmal Tumor

Transcription:

Malignant tumors of melanocytes : Part 3 Deba P Sarma, MD., Omaha

Let s go over one case of melanoma using the following worksheet. Of the various essential information that needs to be included in the diagnosis (diagnosis with subtype, tumor thickness in mm, presence or absence of ulceration, mitotic rate, level of invasion, margin status and pathologic stage), most critical items are the diagnosis of melanoma, tumor thickness and presence or absence of ulceration. Diagnosis: SKIN, SITE,BIOPSY / EXCISION: - Diagnosis with subtype -Tumor thickness (Breslow depth): mm -Ulceration: Absent / Present -Mitotic rate: 0 or 1 or more/ mm 2 -Level of invasion (Clark level): -Margin status: Negative / Positive -Pathologic stage: ADDITIONAL OPTIONAL INFORMATION: Microsatellitosis: Absent/ Present Dense tumor-infiltrating lymphocytes: Absent / present Histologic subtype: Lentigo Maligna / Superficial spreading / Nodular / Acral lentiginous / Desmoplastic Clark s Level: I (in situ), II (papillary dermis), III (up to papillary-reticular interface), IV (reticular dermis), V (subcutis) Pathologic Stage: (ptnm): ptx Primary tumor cannot be assessed PTO No evidence of primary tumor ptis Melanoma in-situ pt1a Melanoma 1 mm or less thick, no ulceration and mitosis 0 per mm squared pt1b Melanoma 1 mm or less thick, with ulceration or mitosis 1 or more per mm squared pt2a Melanoma 1.01 2 mm thick, no ulceration pt2b Melanoma 1.01-2 mm thick, with ulceration pt3a Melanoma 2.01 4 mm thick, no ulceration pt3b Melanoma 2.01 4 mm thick, with ulceration pt4a Melanoma > 4 mm thick, no ulceration pt4b Melanoma > 4 mm thick, with ulceration Regional Lymph Nodes (pn) Distant Metastasis (pm)

Case 1. F 67, dorsal left hand, biopsy Let s scan the slide in 4X No ulceration What do we see? - Epidermis is slightly raised, intact, hyperkeratotic. NO ULCERATION. - A tumor starting from the basal layer growing laterally as well as downwards in the papillary dermis. So the level of invasion is Level II (Papillary dermis). - Both lateral margins (lateral to thin red arrows) and the deep MARGINS ARE NEGATIVE for tumor. - In higher magnification, you see the highly pleomorphic, pigmented neoplastic melanocytes from the basal nests extending in the papillary dermis are growing into tumor clones. The overlying epidermis does not show neoplastic melanocytes with pale cytoplasm (Pagetoid cells). - Your diagnosis is: Melanoma, lentigo maligna type or simply Lentigo maligna melanoma.

Now, let s look at 10X Tumor thickness: 0.30 mm You have to measure the tumor thickness at 10X using a micro-oculometer. You scan the deep part of the tumor and find the deepest clone (a clump of at least 4-5 neoplastic cells) and measure from the deepest tumor margin to the top of the granular layer of the epidermis. Micro-oculometer has a scale reading 1 mm divided in 100 lines it is a direct read-out. You may measure three different areas and record the maximum thickness (remember, it is not the average of 3 readings! It is the deepest measurement).

Now, we have to count mitotic rate of this melanoma. We scan the tumor islands only in the dermis (not at the basal epidermis) at 40X, count the number of mitosis in 4 active areas (hot zones), and record them as : Number of mitosis per mm 2 Mitotic figure After scanning 4 different areas in the dermis I counted 2 mitosis per mm squared. This will be recorded as: Mitotic rate: > 1 per mm2

Now, two optional information Microsatellitosis is defined as small tumor islands, 0.05 mm or larger in size in the reticular dermis or subcutis separated from the main tumor by at least 0.3 mm. We record our case as : Microsatellitosis: Absent Dense tumor-infiltrating lymphocytes: Present Lymphocytes Melanoma

Now, let s look at the worksheet, and figure out the Pathologic stage for this case Pathologic Stage: (ptnm): ptx Primary tumor cannot be assessed PTO No evidence of primary tumor ptis Melanoma in-situ pt1a Melanoma 1 mm or less thick, no ulceration and mitosis 0 per mm squared pt1b Melanoma 1 mm or less thick, with ulceration or mitosis 1 or more per mm squared pt2a Melanoma 1.01 2 mm thick, no ulceration pt2b Melanoma 1.01-2 mm thick, with ulceration pt3a Melanoma 2.01 4 mm thick, no ulceration pt3b Melanoma 2.01 4 mm thick, with ulceration pt4a Melanoma > 4 mm thick, no ulceration pt4b Melanoma > 4 mm thick, with ulceration Regional Lymph Nodes (pn) Distant Metastasis (pm) Our findings in this case are: Primary Tumor (pt): 0.30 mm thick, no ulceration, mitotic rate >1 per mm2 Regional Lymph Nodes (pn): X (unknown) Distant Metastasis: X (unknown) Pathologic stage is recorded as: pt1b, pnx, pmx

Now, let s write the final diagnosis Diagnosis: SKIN, dorsal left hand,biopsy : -Melanoma, lentigo maligna type -Tumor thickness (Breslow depth): 0.30 mm -Ulceration: Absent -Mitotic rate: > 1/ mm 2 -Level of invasion (Clark level): II -Margin status: Negative -Pathologic stage: pt1b, pnx, pmx Additional information: Microsatellitosis: Absent Dense tumor-infiltrating lymphocytes: Present ds

Let s go over a few important points: Diagnosis of melanoma is usually done at 4X or 10X magnification, mostly from the alteration of growth pattern of melanocytes. Thickness of melanoma is measured at 10X magnification using a micro-oculometer. Thickness of the tumor is measured from deepest part of the tumor to the top of granular layer of the epidermis. In case the overlying epidermis is ulcerated, thickness is measured from deepest part of the tumor to the base of ulcer. Mitotis is counted in the invasive part of the tumor (not at basal area) in the active part of the tumor at 40X magnification. Suggestion: You have to sit with your staff pathologist or dermatopathologist to practice reading melanoma using a binocular or a multiheaded microscope. You have to read several cases before you feel confident. After a while, it will be your second nature. Deba P Sarma, MD., Omaha